ASIT biotech successfully completes the second tranche of its capital increase, reaching a total amount raised of €13.9 million

LIVE : 2.595 EUR

FR
EN

About
Company
Allergy

Medical Need
Therapeutic strategies & Market

Platform

ASIT+™ Platform ^TM
Production process
Mode of action

Leadership

Management
Board of Directors
Scientific Advisory Board

Partners Welcome
Pipeline
Pipeline
gp-ASIT+^TM
hdm-ASIT+^TM
pnt-ASIT+^TM
Other programs
Scientific Publications
Investors
Share information

Share price
Shareholder structure
Analysts Coverage

Shareholders meetings

EGM of November 14, 2019
EGM of June 28, 2019
OGM of June 13, 2019
EGM of December 17, 2018
OGM of June 14, 2018
EGM of December 7, 2017
EGM of June 8, 2017
OGM of June 8, 2017
AGM of June 30, 2016

Financial Information

Financial Calendar & Events
Annual Reports
Corporate Information
Corporate presentations

Corporate Governance
Audit Committee
Compensation and Nomination Committee
FSMA Regulated Information
Scientific Publications
Press releases & media
Press releases
Videos
Career
Spontaneous Applications
Contact

180223_PR_ASIT_Financement_Tranche2_EN_vf.pdf

ASIT biotech successfully completes the second tranche of its capital increase, reaching a total amount raised of €13.9 million